Company Filing History:
Years Active: 2011
Title: Yves Mely: Innovator in Cell Apoptosis Detection
Introduction
Yves Mely is a notable inventor based in La Wantzenau, France. He has made significant contributions to the field of cell biology, particularly in the detection and quantification of cell apoptosis. His innovative work has implications for understanding various diseases that involve cell death.
Latest Patents
Yves Mely holds a patent for "Compounds and kits for the detection and the quantification of cell apoptosis." This patent focuses on 3-hydroxyflavone derivatives, which are useful in detecting and quantifying cell apoptosis. These derivatives serve as fluorescent probes for studying lipid asymmetry in cell plasma membranes and for identifying apoptotic cells. Furthermore, they can be utilized to monitor the progression of diseases associated with cell apoptosis.
Career Highlights
Throughout his career, Yves Mely has worked with esteemed institutions such as the Centre National de la Recherche Scientifique and Université Louis Pasteur Strasbourg I. His research has contributed to advancements in the understanding of cellular processes and their implications in health and disease.
Collaborations
Yves Mely has collaborated with notable researchers, including Andrey Klymchenko and Oleksandr Demchenko. These collaborations have further enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Yves Mely's contributions to the field of cell apoptosis detection highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to influence research in cell biology and disease monitoring.